HOME >> BIOLOGY >> NEWS
Overweight Cats Risk Disease And Premature Death, Cornell Study Finds

ITHACA, N.Y. -- Seriously overweight cats are more likely to suffer diabetes mellitus, lameness and non-allergic skin conditions, a Cornell University veterinarian's four-year follow-up to a feline obesity study has shown.

Most likely to be tubby are neutered, apartment-dwelling, mixed breed cats eating prescription cat food.

"The original obesity study and the follow-up confirm what veterinarians and cat owners have suspected for a long time," said Janet M. Scarlett, D.V.M., associate professor of epidemiology in Cornell's College of Veterinary Medicine. "Too much extra weight is not healthy for the cats, but being very thin can be a problem, too."

Scarlett was a collaborator, along with veterinary nutritionist Susan Donoghue, in the landmark 1989 study of 2,000 cats at 31 veterinary clinics in the Northeast, as well as the principal investigator of the tracking study. The Waltham Centre for Pet Nutrition in the United Kingdom funded the first study, which found that about 25 percent of cats brought to veterinarians are overweight: 20 percent were ranked as "heavy" by veterinarians and 5 percent were considered "obese." Slightly more pet owners -- about 29 percent -- thought their cats were overweight in the same survey.

Ralston Purina Co., the American pet food manufacturer, funded the four-year follow-up, in which Cornell veterinary students called as many of the original pet owners as they could locate and asked about the cats' health. Researchers also reviewed veterinarians' medical records for the animals in the first survey. Among the findings:

  • Overweight cats, including those considered "heavy" and "obese," are four-and-a-half times more likely to develop diabetes mellitus, compared to optimal weight cats.

  • Obese cats are seven times more likely to require veterinary care for lameness, caused by joint diseases such as arthritis or muscle injuries, compared to optimal weight cats. Heavy cats
    '"/>


Contact: Roger Segelken
hrs2@cornell.edu
607-255-9736
Cornell University News Service
1-Apr-1997


Page: 1 2 3 4

Related biology news :

1. Disease diagnosis, drug development focus of UH profs biochip research
2. Disease-resistant papaya saves Hawaiian papaya industry
3. APS Inflammatory Bowel Diseases Translational Research Conference, Sept. 8-11
4. 1st International Conference on Cell Therapy for Cardiovascular Disease
5. Disease threatens cucumbers, pumpkins, and other vine crops
6. Disease-fighters in our mouths provide clues to enhancing the immune system
7. International Conference on Emerging Infectious Diseases
8. NIH establishes Rare Diseases Clinical Research Network
9. Shedding Light on Disease: A Briefing for Journalists
10. Disease-causing genetic mutations in sperm increase with mens age
11. World Congress on Huntingtons Disease to meet in Toronto, August 16-19, 2003

Post Your Comments:
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... 26, 2015 Agnition announced today that ... American Farmer, airing for the first time at 7:30 ... American Farmer will explore the extremely important role soil ... with a patented Microbial Catalyst™ technology that enhances soil ... The segment will air again on April 28. , ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Laboratory ... Top-Loading Balances and Analytical Balances to get best-performing ... line of weighing balances from the trusted brand ... Balances increase your efficiency by providing a ... of samples. Weighing modes include parts counting, percent ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
Cached News: